AVS
David Long is an experienced finance leader with over 20 years of global experience. David joined Corindus Vascular Robotics in September 2011 as Senior Vice President and CFO, leading the company through an IPO and the eventual acquisition by Siemens Healthiness for $1.1B in 2019.
This person is not in the org chart
This person is not in any offices
AVS
AVS is an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2018 by Hitinder Gurm, M.D., Interventional Cardiologist and Chief Clinical Officer at University of Michigan, and Robert Chisena, Ph.D., Chief Technical Officer at AVS. They are redefining interventional therapy for severely calcified lesions with their Pulse IVL System, which uses a novel pulsatile mechanism of action to shatter calcium and expand narrowed vessels, all with a single device.